About
TargTex develops targeted localized therapies for hard-to-treat central nervous system cancers, focusing primarily on glioblastoma by using selective small molecules as adjuncts to surgery.
Explore TargTex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.